These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8162409)

  • 21. Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination.
    Tourdot S; Oukka M; Manuguerra JC; Magafa V; Vergnon I; Riché N; Bruley-Rosset M; Cordopatis P; Kosmatopoulos K
    J Immunol; 1997 Sep; 159(5):2391-8. PubMed ID: 9278330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.
    Fan S; Wu Y; Wang S; Wang Z; Jiang B; Liu Y; Liang R; Zhou W; Zhang N; Xia C
    J Virol; 2016 Aug; 90(15):6625-6641. PubMed ID: 27170754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.
    Rudensky AYu ; Preston-Hurlburt P; al-Ramadi BK; Rothbard J; Janeway CA
    Nature; 1992 Oct; 359(6394):429-31. PubMed ID: 1328884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.
    Murphy B; Magee CC; Alexander SI; Waaga AM; Snoeck HW; Vella JP; Carpenter CB; Sayegh MH
    J Clin Invest; 1999 Mar; 103(6):859-67. PubMed ID: 10079107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.
    Berzofsky JA; Pendleton CD; Clerici M; Ahlers J; Lucey DR; Putney SD; Shearer GM
    J Clin Invest; 1991 Sep; 88(3):876-84. PubMed ID: 1715888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules.
    Hervé M; Maillere B; Mourier G; Texier C; Leroy S; Ménez A
    Mol Immunol; 1997 Feb; 34(2):157-63. PubMed ID: 9188848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
    Nakaya Y; Zheng H; García-Sastre A
    Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
    Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
    Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
    J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipopeptide particles as the immunologically active component of CTL inducing vaccines.
    Tsunoda I; Sette A; Fujinami RS; Oseroff C; Ruppert J; Dahlberg C; Southwood S; Arrhenius T; Kuang LQ; Kubo RT; Chesnut RW; Ishioka GY
    Vaccine; 1999 Feb; 17(7-8):675-85. PubMed ID: 10067673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the insulin A-chain major immunogenic determinant presented by MHC class II I-Ad molecules.
    Williams DB; Ferguson J; Gariepy J; McKay D; Teng YT; Iwasaki S; Hozumi N
    J Immunol; 1993 Oct; 151(7):3627-37. PubMed ID: 7690808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of chimeric vaccines constructed with PEP-1 and Ii-Key linking to a hybrid epitope from heterologous viruses.
    Liu XL; Shan WJ; Xu SS; Zhang JJ; Xu FZ; Xia SL; Dai Y
    Biologicals; 2015 Sep; 43(5):377-82. PubMed ID: 26153399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes.
    Wang Y; Smith JA; Gefter ML; Perkins DL
    J Immunol; 1992 May; 148(10):3034-41. PubMed ID: 1578129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of the inhibitory amino acid for epitope peptide binding onto major histocompatibility complex class II molecules enhances immunogenicity of the antigen.
    Chang SH; Kim J; Lee KY; Kim HJ; Chung YJ; Park CU; Kim BS; Jang YS
    Scand J Immunol; 2004 Feb; 59(2):123-32. PubMed ID: 14871288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
    Suh CH; Freed JH; Cohen PL
    J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope selection and design of synthetic vaccines. Molecular approaches to enhancing immunogenicity and cross-reactivity of engineered vaccines.
    Berzofsky JA
    Ann N Y Acad Sci; 1993 Aug; 690():256-64. PubMed ID: 7690214
    [No Abstract]   [Full Text] [Related]  

  • 40. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.
    Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP
    J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.